ÂÜÀòÂÒÂ×

Xiaohui is the Chief Technology Officer of EarlyDx. Xiaohui has 20+ years of experience in research and product development. He received interdisciplinary research training across physics, molecular biology, and cancer genomics. Prior to EarlyDx, he was a senior scientist at Cynvenio Biosystems (now LungLife AI). He was the main contributor to Cynvenio’s FISH test in lung cancer early detection using circulating tumor cells in the blood. Xiaohui leads EarlyDx’s NIH SBIR award on assay development. Xiaohui received his Ph.D. in Physics from the City University of New York and completed his postdoctoral training in Cancer Genomics at Harvard University.